AVI BioPharma names Garabedian CEO

AVI BioPharma Inc. (NASDAQ:AVII) named Chris Garabedian, a director, as president and CEO, effective Jan. 1. He is the former VP of corporate strategy at Celgene Corp. (NASDAQ:CELG). Garabedian replac...